Bastiano Sanna, EVP, Cell & Genetic Therapies: Vertex Pharmaceuticals VRTX Sell · Filed 23/03/20

Trade details

Type: Insider sale
Amount: $745,940.28
Shares · price: 2,482 sh · $300.54 a share
Held after: 49,532 sh
Stock: Vertex Pharmaceuticals VRTX
Person: Bastiano SannaEVP, Cell & Genetic Therapies
Trade date: 23/03/16
Filed: 23/03/20
Days to filing: 4 days

Sold 4.8% of holdings

Share of holding sold: 4.8%

Vertex Pharmaceuticals trades, last 26 weeks

What else happened in Vertex Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 23/02/14~23/04/15

Bastiano Sanna's recent trades

Bastiano SannaEVP, Cell & Genetic Therapies
Sell10b5-1 planVertex Pharmaceuticals
Sell10b5-1 plan
Vertex Pharmaceuticals
VRTX
$997.5K
2,850 sh
$997.5K
Filed 23/05/09
Traded 23/05/08
Bastiano SannaEVP, Cell & Genetic Therapies
Sell10b5-1 planVertex Pharmaceuticals
Sell10b5-1 plan
Vertex Pharmaceuticals
VRTX
$147.7K
422 sh
$147.7K
Filed 23/05/09
Traded 23/05/05
Bastiano SannaEVP, Cell & Genetic Therapies
Sell10b5-1 planVertex Pharmaceuticals
Sell10b5-1 plan
Vertex Pharmaceuticals
VRTX
$719.5K
2,053 sh
$719.5K
Filed 23/05/04
Traded 23/05/03
Bastiano SannaEVP, Cell & Genetic Therapies
Sell10b5-1 planVertex Pharmaceuticals
Sell10b5-1 plan
Vertex Pharmaceuticals
VRTX
$494.3K
1,411 sh
$494.3K
Filed 23/05/04
Traded 23/05/02
Bastiano SannaEVP, Cell & Genetic Therapies
Sell10b5-1 planVertex Pharmaceuticals
Sell10b5-1 plan
Vertex Pharmaceuticals
VRTX
$256K
728 sh
$256K
Filed 23/05/04
Traded 23/05/03

Bastiano Sanna, EVP — sold $745.9K of Vertex Pharmaceuticals VRTX · 4.8% of holdings · 10b5-1 plan | Whalegun